The WACC of Maat Pharma SA (MAAT.PA) is 8.6%.
| Range | Selected | |
| Cost of equity | 7.90% - 10.40% | 9.15% |
| Tax rate | 25.90% - 27.10% | 26.50% |
| Cost of debt | 4.00% - 7.00% | 5.50% |
| WACC | 7.4% - 9.9% | 8.6% |
| Category | Low | High |
| Long-term bond rate | 3.0% | 3.5% |
| Equity market risk premium | 5.8% | 6.8% |
| Adjusted beta | 0.85 | 0.95 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.90% | 10.40% |
| Tax rate | 25.90% | 27.10% |
| Debt/Equity ratio | 0.13 | 0.13 |
| Cost of debt | 4.00% | 7.00% |
| After-tax WACC | 7.4% | 9.9% |
| Selected WACC | 8.6% | |